Merck (MRK) Other Operating Expenses (2010 - 2011)
Merck's (MRK) quarterly Other Operating Expenses came in at $500.0 million in Q1 2011, up 152.63% quarter-over-quarter from -$950.0 million in Q3 2010.
Analysis
Merck (MRK) Other Operating Expenses (2010 - 2011) Analysis & Trends
Merck (MRK) has reported Other Operating Expenses for 2 consecutive years, with $500.0 million the latest figure, recorded in Q1 2011.
- On a quarterly basis, Other Operating Expenses changed N/A year-over-year to $500.0 million in Q1 2011; TTM through Dec 2011 was $500.0 million, a 152.63% increase from a year earlier, with the FY2010 full-year figure at -$950.0 million, changed N/A from the prior year.
- Other Operating Expenses was $500.0 million for Q1 2011 at Merck, up from -$950.0 million in the prior quarter.
- Over five years, Other Operating Expenses peaked at $500.0 million in Q1 2011 and troughed at -$950.0 million in Q3 2010.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 650.65 Bn | 629.89 Bn | 17.26 Bn |
| 2 | AbbVie | 466.34 Bn | 459.82 Bn | 12.70 Bn |
| 3 | Merck | 362.11 Bn | 355.02 Bn | 12.21 Bn |
| 4 | Novartis Ag | 267.81 Bn | 260.52 Bn | 11.24 Bn |
| 5 | Pfizer | 157.31 Bn | 145.91 Bn | 10.94 Bn |
| 6 | Bristol Myers Squibb | 128.75 Bn | 117.69 Bn | 9.25 Bn |
| 7 | Sanofi | 51.80 Bn | 44.84 Bn | 10.79 Bn |
| 8 | Revolution Medicines | 40.91 Bn | 40.91 Bn | - |
| 9 | BeOne Medicines | 39.65 Bn | 34.55 Bn | 1.53 Bn |
| 10 | Incyte | 25.18 Bn | 20.65 Bn | 1.57 Bn |